Delivery Order SPE2DB20D3101-SPE2DB25FRTC0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,296.18 to AmerisourceBergen Drug Corp for Lokelma 5 gram powder packets (30-count packaging) on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for LOKELMA 10 gram powder packets (30-count packaging) with a ceiling value of $1,205.17. This competitive, non-set-aside award utilizes a firm fixed price delivery order contract type, with performance based in Conshohocken, Pennsylvania, and an ultimate completion date of August 12, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,638.62 to AmerisourceBergen Drug Corp for Lokelma 10 gram powder packets (30-count package). This non-competitive delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed price pharmaceutical supply under the company's existing contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,655.97 to AmerisourceBergen Drug Corp for Lokelma 5 Gram Powder Packet 30s on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, will be performed in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $1,548.63 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Lokelma 10 gram powder packets (30-count units). This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement with an ultimate completion date of August 1, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,187.23 to AmerisourceBergen Drug Corp for Lokelma 10 gram powder packets (30-count) on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply for federal medical needs. The award is not designated as a set-aside contract and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $12,357.58 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Lokelma 5 gram powder packets (30-count units). This is a non-set-aside contract with an ultimate completion date of August 14, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's corporate office location in...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lokelma, a 10-gram powder packet medication, with a ceiling value of $1,128.03 and a performance period through April 2025. The award is not associated with a set-aside program and is considered an open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- This is a $6,326.16 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LOKELMA 5 gram powder packets, which are used to treat hyperkalemia. The contract has an ultimate completion date of April 10, 2023 and was awarded on April 9, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) that...
- The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide LOKELMA 10 gram powder packets. This $1,224.44 firm fixed price contract has a completion date of February 21, 2024. AmerisourceBergen Drug Corp is a prime contractor that holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRTC0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Lokelma 5 gram powder packets (30-count units) with a contract ceiling value of $1,853.40. This firm fixed-price delivery order, which is set to be completed by August 21, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made on a non-set-aside, competitive basis, demonstrating the contractor's capability to meet federal pharmaceutical procurement standards through open competition. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. AmerisourceBergen serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a comprehensive range of medications, vaccines, and medical supplies across multiple therapeutic domains. Lokelma, a potassium-binding medication, supports the Defense Health Agency and other federal healthcare entities' operational needs through this flexible contract vehicle, which enables efficient delivery of essential pharmaceutical commodities to support military health programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/20/25 |